N. Sugasaki

Unusual hyperporphyrin spectrum by bis(glutathione dimethyl ester)-hemin complex, a model of cytochrome P-450-thiolate complexes.

H. Sakurai, K. Tsuchiya, M. Shibuya, 1990, Biochemical and biophysical research communications.

Efficacy of S‐1 after pemetrexed in patients with non‐small cell lung cancer: A retrospective multi‐institutional analysis

M. Fukuda, H. Taniguchi, H. Mukae, 2021, Thoracic cancer.

Running Title : Pharmacokinetic parameters of gefitinib as predictors Clinical Trial Registration

M. Fukuda, Shuntaro Sato, H. Mukae, 2018 .

Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations

M. Fukuda, Shuntaro Sato, H. Mukae, 2016, Cancer Chemotherapy and Pharmacology.

Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer

Y. Obase, M. Shimada, M. Fukuda, 2019, Thoracic cancer.

Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use

Y. Obase, K. Omagari, H. Mukae, 2019, The American journal of case reports.

Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study

M. Shimada, H. Mukae, H. Soda, 2023, Thoracic cancer.

Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations

M. Fukuda, Shuntaro Sato, H. Mukae, 2016, Cancer Chemotherapy and Pharmacology.